Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer.

Breast Cancer Res · 2010 · PMC3046429 · PMID 21047409

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

reached borderline significanceP = 0.1so close (0.05 < p ≤ 0.1)

The serum levels of miR141 could not discriminate breast cancer patients from healthy women but the association with the clinical outcome reached borderline significance ( P = 0.1 for progression-free survival in M1 patients and P = 0.06 for recurrence-free survival in M0 patients).

also in 370 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.